Published in Can Respir J on September 01, 2007
Improving clinician self-efficacy does not increase asthma guideline use by primary care clinicians. Acad Pediatr (2012) 1.11
Translation of a pediatric asthma-management program into a community in Connecticut. Pediatrics (2010) 0.90
Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education. Multidiscip Respir Med (2014) 0.88
Enablers of Physician Prescription of a Long-Term Asthma Controller in Patients with Persistent Asthma. Can Respir J (2016) 0.77
From best evidence to best practice: effective implementation of change in patients' care. Lancet (2003) 27.61
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest (1998) 3.37
Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can Respir J (2006) 2.25
Clinical practice guidelines and the translation of knowledge: the science of continuing medical education. CMAJ (2000) 1.86
Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ (2005) 1.63
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J (2004) 1.35
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Impacts of a provincial asthma guidelines continuing medical education project: The Ontario Asthma Plan of Action's Provider Education in Asthma Care Project. Can Respir J (2007) 1.00
Towards excellence in asthma management (TEAM): a populational disease-management model. J Asthma (2002) 0.96
Improving knowledge transfer on chronic respiratory diseases: a Canadian perspective. How to translate recent advances in respiratory diseases into day-to-day care. J Nutr Health Aging (2008) 0.91
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. Can Respir J (2003) 3.14
Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health (2012) 3.01
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol (2003) 2.98
Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med (2011) 2.80
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med (2014) 2.53
Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults. Can Respir J (2010) 2.42
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med (2010) 2.31
Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma? CMAJ (2002) 2.30
The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ (2006) 2.20
Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest (2005) 2.15
Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ (2005) 2.12
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85
Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med (2002) 1.73
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med (2006) 1.71
Obesity and asthma: a specific phenotype? Chest (2008) 1.47
Asthma in pregnancy. BMJ (2007) 1.47
Allergen-derived T cell peptides and late asthmatic responses. Am J Respir Crit Care Med (2004) 1.40
Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest (2006) 1.38
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med (2007) 1.35
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J (2004) 1.35
Canadian Thoracic Society COPD Guidelines: summary of highlights for family doctors. Can Respir J (2003) 1.25
Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma. J Allergy Clin Immunol (2009) 1.23
Factors associated with the appropriate use of asthma drugs. Can Respir J (2011) 1.18
Evaluation of a program aimed at increasing referrals for asthma education of patients consulting at the emergency department for acute asthma. Chest (2004) 1.16
The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. J Allergy Clin Immunol (2003) 1.13
Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J Allergy Clin Immunol (2007) 1.10
Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008. J Allergy Clin Immunol (2008) 1.08
Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report. Chest (2015) 1.07
Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. Ann Allergy Asthma Immunol (2006) 1.06
Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life. Rural Remote Health (2010) 1.06
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med (2008) 1.03
Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol (2002) 1.03
Pleural effusions following cardiac surgery: prevalence, risk factors, and clinical features. Chest (2009) 1.02
Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med (2006) 1.02
Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg (2004) 1.00
Canadian Thoracic Society: Presenting a new process for clinical practice guideline production. Can Respir J (2009) 1.00
Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Can Respir J (2010) 0.96
The determinants of prevalence of health complaints among young competitive swimmers. Int Arch Occup Environ Health (2006) 0.96
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast. J Asthma (2010) 0.95
Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. Can Respir J (2003) 0.95
CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. Toxicol Sci (2012) 0.93
Understanding allergic asthma from allergen inhalation tests. Can Respir J (2007) 0.93
Inhaled allergen bronchoprovocation tests. J Allergy Clin Immunol (2013) 0.91
The effect of neonatal bacille Calmette-Guérin vaccination on purified protein derivative skin test results in Canadian aboriginal children. Chest (2007) 0.90
Respiratory health of elite athletes - preventing airway injury: a critical review. Br J Sports Med (2012) 0.90
Alveolar macrophage subpopulations in bronchoalveolar lavage and induced sputum of asthmatic and control subjects. J Asthma (2009) 0.89
Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults: executive summary. Can Respir J (2012) 0.89
Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis. Otolaryngol Head Neck Surg (2009) 0.89
Symposium on obesity and asthma - November 2, 2006. Can Respir J (2007) 0.89
Obesity, allergy and immunology. J Allergy Clin Immunol (2005) 0.88
Asthma and exercise-induced bronchoconstriction in athletes. N Engl J Med (2015) 0.88
Are questionnaires on respiratory symptoms reliable predictors of airway hyperresponsiveness in athletes and sedentary subjects? J Asthma (2003) 0.88
Pan-Canadian REspiratory STandards INitiative for Electronic Health Records (PRESTINE): 2011 national forum proceedings. Can Respir J (2012) 0.88
Fibroblast growth factor-2 is a sputum remodeling biomarker of severe asthma. J Asthma (2013) 0.88
Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis. Int J Chron Obstruct Pulmon Dis (2010) 0.88
Decreased miR-192 expression in peripheral blood of asthmatic individuals undergoing an allergen inhalation challenge. BMC Genomics (2012) 0.87
TGF-beta suppresses EGF-induced MAPK signaling and proliferation in asthmatic epithelial cells. Am J Respir Cell Mol Biol (2007) 0.87
Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects. Respir Res (2011) 0.87
Comparison of two in vitro models of cigarette smoke exposure. Inhal Toxicol (2009) 0.87
Genetic variations in taste receptors are associated with chronic rhinosinusitis: a replication study. Int Forum Allergy Rhinol (2014) 0.87
Cartography of emergency department visits for asthma - targeting high-morbidity populations. Can Respir J (2004) 0.86
Obesity and asthma control in an urban population. J Allergy Clin Immunol (2010) 0.86
Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. Curr Med Res Opin (2005) 0.86
The relationships between atopy, rhinitis and asthma: pathophysiological considerations. Curr Opin Allergy Clin Immunol (2003) 0.85
Active smoking status in chronic rhinosinusitis is associated with higher serum markers of inflammation and lower serum eosinophilia. Int Forum Allergy Rhinol (2014) 0.85
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest (2006) 0.85
Leptin and adiponectin in obese and non-obese subjects with asthma. Biomarkers (2011) 0.84
Investigation of occupational asthma: Do clinicians fail to identify relevant occupational exposures? Can Respir J (2015) 0.84
Airway remodeling and inflammation in competitive swimmers training in indoor chlorinated swimming pools. J Allergy Clin Immunol (2011) 0.83
The respiratory health of swimmers. Sports Med (2009) 0.83
Characteristics and medical resource use of asthmatic subjects with and without work-related asthma. J Allergy Clin Immunol (2007) 0.83
A kit to facilitate and standardize the processing of sputum for measurement of airway inflammation. Can Respir J (2013) 0.82
Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma. Toxicol Sci (2012) 0.82
Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α. J Allergy Clin Immunol (2011) 0.82
Discordance between asthma control clinical, physiological and inflammatory parameters in mild asthma. Respir Med (2013) 0.82
Tissue-engineered human asthmatic bronchial equivalents. Eur Cell Mater (2004) 0.82
Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol (2008) 0.81
Expiratory flows and airway inflammation in elderly asthmatic patients. Respir Med (2011) 0.81
[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. Can Respir J (2004) 0.81
Asthma and rhinitis: what is the relationship? Curr Opin Allergy Clin Immunol (2012) 0.81
Quality assurance of spirometry in a population-based study -predictors of good outcome in spirometry testing. COPD (2014) 0.81
Prevalence of respiratory symptoms in an athlete population. Respir Med (2003) 0.81
Comparison of cell fixation methods of induced sputum specimens: an immunocytochemical analysis. J Immunol Methods (2005) 0.81
Optimization of the conditions for preservation of induced sputum: influence of freezing on cellular analysis. Chest (2005) 0.80
Gene-metabolite expression in blood can discriminate allergen-induced isolated early from dual asthmatic responses. PLoS One (2013) 0.80
Airway dysfunction in swimmers. Br J Sports Med (2012) 0.80
Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma. Toxicol Sci (2013) 0.80